Posts by Sandra Ansanay-Alex
Claire Charmet is the New CEO of CHUV
The new CEO of CHUV took up her position on 1 June 2025. Claire Charmet is already familiar with the institution, having observed it in her role as a member of the strategic council. She has made hospital management her career for the past 15 years. Aged 42, Claire Charmet has been managing the…
Read MoreBio Asia-Taiwan
BIO Asia–Taiwan will be held from 14 to 18 July 2027 in Tapei, Taiwan The event brings together bioindustry executives and investors from North America, Europe and Asia to explore business opportunities and to engage with Taiwan’s emerging biotech sector. The five-day gathering includes a three-day conference featuring internationally-renowned speakers, company presentations from Asia and…
Read More11 Swiss Life Sciences projects selected by MassChallenge
MassChallenge Switzerland, part of the global MassChallenge network, announced the 103 early-stage startups selected for the 2025 accelerator programme. 11 Swiss Life Sciences projects are in the list. Healthtech Actival (Switzerland): Actival has a patented approach of directly manufacturing clear dental aligners with integrated microfluidic channels. These microfluidic channels act as reservoirs that slowly release beneficial antibacterial…
Read MoreBIOKET
BIOKET, the bioeconomy forum, is taking place from 9 to 11 March 2027 in Strasbourg (France). BIOKET brings together industry leaders, technology providers, startups, researchers, investors, clusters and decision-makers looking to accelerate the transition from innovation to industrial deployment.After another impactful edition, BIOKET continues its mission to accelerate the industrialization of bio-based innovations. 🗓 9 – 11 March…
Read MoreSwiss Health Valley Startups Shine at Major Pitching Events
The Swiss Health Valley continues to be a powerhouse of innovation, as multiple startups made their mark at major pitching events across Europe. These groundbreaking companies are not only transforming health and wellness but also bringing international recognition to the region. At Start Contest 2024-2025, PMAX Labs emerged as the grand prize winner…
Read MoreInnobooster Gebert Rüf Stiftung
Apply before 1 December 2026 for the Gebert Rüf Stiftung Innobooster and get up to a CHF 150,000 support Gebert Rüf Stiftung supports university-based, high-potential businesses from the Venture Kick program with the aim of substantially accelerating their market entry. The funding line is calling for top talents with convincing proposals of how a research…
Read MoreSyrhatech Completes A CHF 4.5 Million Financing Round
Syrhatech, a French-Swiss CDMO innovating in the development and manufacture of injectable medical devices based in particular on hyaluronic acid, announces the closing of an investment of CHF 4.5 million, completed with strategic investors. Funding for innovation and industrial capacity This investment will enable Syrhatech to strengthen its R&D team at its site in Geneva, and to deploy a…
Read MorePANORAMAI
Panoramai is taking place from 3 to 5 June 2025 at Campus Unlimitrust in Renens Within the Gen AI ecosystem, discover real-life use cases and AI-powered digital transformation stories with entrepreneurs and business experts. The event also aims to enrich the horizons and potential applications of AI by exploring creative perspectives on uses and…
Read MoreNewBiologix Licences Xcell-Eng-HEK293 Cell Line to Recipharm
NewBiologix, a Biopôle-based (Vaud)Swiss biotech innovator, has granted a non-exclusive licence to Recipharm Advanced Bio. The agreement gives Recipharm access to NewBiologix’s Xcell-Eng-HEK293 cell lines, enabling the efficient production of recombinant Adeno-Associated Viruses (rAAVs) for cell and gene therapies. The licensed cell lines offer high-yield, GMP-ready viral production, accelerating the path to clinical trials.…
Read MoreHedera Dx Secures €15 Million Series A
Hedera Dx Raises €15M Series A to Expand Access to Precision Oncology Across Europe Hedera Dx, a Vaud-Based techbio company advancing precision cancer care, announced the successful close of a €15 million Series A financing round. The round was led by Vsquared Ventures, with new investor Tesi joining and strong support from existing backers…
Read More